Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

Novartis, an innovative medicines company, has announced plans to invest $23 billion over 5 years in U.S.-based ...

Arcutis Biotherapeutics Inc. has announced that David Topper, Arcutis’ chief financial officer (CFO) is retiring from the ...

Increases its competitiveness in the field of drug containment solutions and builds the largest ampoule manufacturing ...

IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, has partnered with ...

Curium has acquired Nucleis, a specialist in GMP manufacturing and distribution of PET radiopharmaceutical drugs.

In his new role, Chen will enhance shareholder value and guide Harbour BioMed through its next phase of strategic development ...

Rivus Pharmaceuticals, Inc., announced the expansion of its leadership team and the opening of a South San Francisco office ...

Source BioScience UK Ltd, a provider of genomic services and histopathology diagnostics, has acquired Cambridge Clinical ...

Prolerity Clinical Research, a clinical research site network, has appointed Stacey Johnson as its new Chief Operating ...

PharmaLogic Holdings Corp., a CDMO specializing in radiopharmaceuticals, has agreed to acquire a majority stake in Agilera ...

Programs will leverage ABL Bio's Grabody-B platform technology to deliver molecules across the blood-brain barrier.